Supplementary Online Content

Size: px
Start display at page:

Download "Supplementary Online Content"

Transcription

1 Supplementary Online Content Song Z, Ayanian JZ, Wallace J, He Y, Gibson TB, Chernew ME. Unintended consequences of eliminating Medicare payments for consultations. JAMA Intern Med. Published online November 26, doi: /jamainternmed emethods. Study Population Inclusion Criteria etable 1. Change in Fees Between 2009 Consultations and 2010 Office Visits (the Effective Fee Cut) etable 2. Change in Office Visit Fees From 2009 to 2010 (the Compensatory Fee Increase) etable 3. Definitions of Clinical Complexity etable 4. Sensitivity Analyses This supplementary material has been provided by the authors to give readers additional information about their work.

2 Unintended consequences of eliminating Medicare payments for consultations e-methods. Study population inclusion criteria Our study population was drawn from the Thomson Reuters MarketScan Medicare Supplemental claims database and included Medicare beneficiaries who had any of the ICD-9 diagnoses listed in (1) or had any claim for a prescription medication belonging to a class of drugs listed in (2). Given our non-randomly drawn sample of Medicare beneficiaries, we adjust all analyses using the Centers for Medicare and Medicaid Services Hierarchical Condition Category (CMS-HCC) risk-adjustment system (version 2010), which uses nationally-representative coefficients derived using age, sex, and clinical diagnoses. The CMS- HCC score is used in risk adjustment of payments for Medicare Advantage plans. For all analyses, we also included sensitivity analyses in which the risk scores are omitted (e-table 4). 1. Any individual who have an International Classification of Diseases, 9th edition (ICD-9) diagnosis of ANY of the following: ( ) hypertensive diseases ( ) ischemic heart disease ( ) pulmonary heart diseases ( ) heart failure and related diseases ( ) cerebrovascular diseases ( ) vascular diseases ( ) other vascular diseases ( ) diabetes mellitus OR 2. Any individual who had a claim for ANY of the following prescription medications: HMG-CoA reductase inhibitors (statins) Other lipid-lowering agents Diuretics ACE inhibitors Angiotensin II receptor blockers (ARBs) Vasodilators Beta-blockers Antiarrhythmics Cardiac glycosides

3 e-table 1. Change in professional fees between 2009 consultations and 2010 office visits (the effective fee cut)* Consultation fees in 2009 Office visit fees in 2010 HCPCS code Fee ($) HCPCS code Fee ($) % Change (new) (lowest complexity) (estab.) (new) (estab.) (new) (estab.) (new) (estab.) (new) (highest complexity) (estab.) * On the left hand side are consultation codes ( ) and their 2009 fees, which were eliminated in On the right hand side are 2010 fees for office visits, which physicians were instructed to substitute towards. The % change column describes the change in fees for 2010 office visits compared to 2009 fees for consultations. Codes are office visits for new patients. Codes are office visits for established patients. All fees are national Payment Amounts for outpatient professional fees derived from the Medicare Part B Physician Fee Schedule.

4 e-table 2. Change in office visit fees from 2009 to 2010 (the compensatory fee increase)* HCPCS code 2009 Fee ($) 2010 Fee ($) % Change (new) (estab.) (new) (estab.) (new) (estab.) (new) (estab.) (new) (estab.) * This table shows the change in office visit fees from 2009 to Codes are office visits for new patients. Codes are office visits for established patients. All fees are national Payment Amounts for outpatient professional fees derived from the Medicare Part B Physician Fee Schedule.

5 e-table 3. Definitions of clinical complexity for patient encounters Level of Complexity Description A problem focused history; A problem focused examination; and Straightforward medical decision making. Self limited or minor Consultation (99241) 15 min New office visit (99201) 10 min Established office visit (99211) 5 min An expanded problem focused history; An expanded problem focused examination; and Straightforward medical decision making. Low severity Consultation (99242) 30 min New office visit (99202) 20 min Established office visit (99212) 10 min A detailed history; A detailed examination; and Medical decision making of low complexity. Moderate severity Consultation (99243) 40 min New office visit (99203) 30 min Established office visit (99213) 15 min A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Moderate to high severity Consultation (99244) 60 min New office visit (99204) 45 min Established office visit (99214) 25 min A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Moderate to high severity Consultation (99241) 80 min New office visit (99205) 60 min Established office visit (99215) 40 min The following definitions are shared by the common procedural definition (CPT) coding system, used by most commercial insurers, and the Healthcare Common Procedure Coding System (HCPCS) used by Medicare. and presenting problem(s) are identical for consultations, new office visits, and established office visits.

6 e-table 4. Sensitivity analyses The following table lists interrupted time series estimates of the 2010 Medicare policy s effect on spending and volume, by type of patient encounter as well as for all encounters. The base model results (row 1) are compared to results from sensitivity analyses (rows 2-6). Sensitivity analyses are alterations from the base model. P values are in parentheses. Base model Omit quarter indicators Omit HRR indicators Omit linear trend Omit age, sex, and risk score Continuous 4-year enrollees Adjusted change in spending ($ per beneficiary per quarter) New All office Established Encounters Consults visits office visits Adjusted change in volume (per 100 beneficiaries per quarter) New All office Established Encounters Consults visits office visits -1.4 (p=0.18) (p<0.001) 8.7 (p<0.001) 1.3 (p=0.19) (p=0.18) (p<0.001) (p<0.001) (p=0.19) (p<0.001) (p<0.001) (p<0.001) (p=0.85) (p=0.002) (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p<0.001) (p=0.04) (p<0.001) (p<0.001) (p<0.001) (p=0.42)

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee C-C, Lee M-tG, Chen Y-S. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Internal Medicine. Published online October 5, 2015.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older

More information

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner 2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES

HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Presented by Parul Agarwal, PhD MPH 1,2 Thomas K Bias, PhD 3 Usha Sambamoorthi,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lin Y-S, Chen Y-L, Chen T-H, et al. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA 2 DS 2 -VASc Score. JAMA Netw

More information

PCMH 2018 Enrollment and Update August 25, 2017

PCMH 2018 Enrollment and Update August 25, 2017 PCMH 2018 Enrollment and Update August 25, 2017 Enrollment Requirements Anne Santifer HealthCare Innovations Department of Human Services 2018 Enrollment Requirements A physician practice that is enrolled

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lewington S, Lacey B, Clarke R, et al; China Kadoorie Biobank Consortium. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern

More information

Chapter 6: Healthcare Expenditures for Persons with CKD

Chapter 6: Healthcare Expenditures for Persons with CKD Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial

More information

Pharmacy Technician Course

Pharmacy Technician Course Pharmacy Technician Course VERSION HISTORY SECTION 1: History and Scope of the Pharmacy Technician Scope of the Pharmacy Technician Section 1 Quiz Check Your Knowledge Section 1 Quiz Answers SECTION 2:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA 2 DS 2 -VASc score in predicting ischemic stroke, thromboembolism, and death

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February

More information

Analysis of Low-Value Health Services in the Minnesota All Payer Claims Database

Analysis of Low-Value Health Services in the Minnesota All Payer Claims Database TECHNICAL SPECIFICATIONS AND METHODS SUPPLEMENT Analysis of Low-Value Health Services in the Minnesota All Payer Claims Database MAY 2017 Minnesota Department of Health Health Economics Program 85 E. 7th

More information

Efficiency Methodology

Efficiency Methodology Efficiency Methodology David C. Schutt, MD Bob Kelley Thomson Healthcare October 2007 Overview Definition Clinical Grouping Methods Implementation Considerations Reporting to Physician Organizations Example

More information

2018 MIPS Reporting Family Medicine

2018 MIPS Reporting Family Medicine 2018 MIPS Reporting Family Medicine Quality Reporting Requirements: Report on 6 quality measures or a specialty measure set Include at least ONE outcome or high-priority measure Report on patients of All-Payers

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patientlevel data. Published online

More information

Evidence from a Pharmacy Access Program TERESA B. GIBSON, PHD SENIOR DIRECTOR, HEALTH OUTCOMES OCTOBER 27, 2011

Evidence from a Pharmacy Access Program TERESA B. GIBSON, PHD SENIOR DIRECTOR, HEALTH OUTCOMES OCTOBER 27, 2011 Evidence from a Pharmacy Access Program TERESA B. GIBSON, PHD SENIOR DIRECTOR, HEALTH OUTCOMES OCTOBER 27, 2011 OVERVIEW Gibson TB, Mahoney J, Ranghell K, Cherney BJ, McElwee N. Value-Based Insurance Plus

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction,

More information

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40% Quality ID #118 (NQF 0066): Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction

More information

At the completion of this educational activity, the learner will be able to understand:

At the completion of this educational activity, the learner will be able to understand: Claims vs. Submission: Understanding the Difference Sonia Trepina, MPA Director, Risk Adjustment & Ambulatory CDI Services Enjoin Asheville, NC Brett Senor, MD, CRC, CCDS Physician Associate, CDI Quality

More information

Chapter 4: Cardiovascular Disease in Patients with CKD

Chapter 4: Cardiovascular Disease in Patients with CKD Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%

More information

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Jennifer S. Schultz, PhD; John C. O Donnell, PhD; Ken L. McDonough, MD;

More information

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis

The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis Client Report Milliman Client Report The Cost Burden of Worsening Heart Failure in the Medicare Fee For Service Population: An Actuarial Analysis Prepared by Kathryn Fitch, RN, MEd Principal and Healthcare

More information

HEALTHCARE REFORM. September 2012

HEALTHCARE REFORM. September 2012 HEALTHCARE REFORM Accountable Care Organizations: ACOs 101 September 2012 The enclosed slides are intended to provide you with a general overview of accountable care organizations (ACOs), created within

More information

Based on Medicare FFS Beneficiaries Assigned July 1, 2011 December 31, 2011

Based on Medicare FFS Beneficiaries Assigned July 1, 2011 December 31, 2011 July 2012 Multi-payer Advanced Primary Care Practice (MAPCP) Demonstration Medical Home Feedback Report Based on Medicare FFS Beneficiaries Assigned July 1, 2011 December 31, 2011 Practice Number Practice

More information

Reporting Mammograms for Medicare Patients Coding these preventive procedures depends on the payer.

Reporting Mammograms for Medicare Patients Coding these preventive procedures depends on the payer. Reporting Mammograms for Medicare Patients Coding these preventive procedures depends on the payer. By Barbara Aubry, RN, CPC, CPMA, CHCQM, FABQAURP For 2017, the American Medical Association (AMA) deleted

More information

Translating Health Services Research in Sickle Cell Disease to Policy

Translating Health Services Research in Sickle Cell Disease to Policy Translating Health Services Research in Sickle Cell Disease to Policy Jean L. Raphael, MD, MPH Associate Professor of Pediatrics Baylor College of Medicine Director, Center for Child Health Policy and

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med. 2012;172(2):127-132.

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Jacqueline C. Barrientos, Nicole Meyer, Xue Song, Kanti R. Rai ASH Annual Meeting Abstracts 2015:3301

Jacqueline C. Barrientos, Nicole Meyer, Xue Song, Kanti R. Rai ASH Annual Meeting Abstracts 2015:3301 Characterization of atrial fibrillation and bleeding risk factors in patients with CLL: A population-based retrospective cohort study of administrative medical claims data in the U.S. Jacqueline C. Barrientos,

More information

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years Introduction This document describes methods for calculating the quality performance benchmarks for Accountable

More information

Legislative & Regulatory Update Brad Young, RxPlus Government Affairs

Legislative & Regulatory Update Brad Young, RxPlus Government Affairs Legislative & Regulatory Update 2018 Brad Young, RxPlus Government Affairs Disclosures Brad Young reports no actual or potential conflicts of interest associated with this presentation. 2 Learning Objectives

More information

Cost-Motivated Treatment Changes in Commercial Claims:

Cost-Motivated Treatment Changes in Commercial Claims: Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical

More information

Jae Jin An, Ph.D. Michael B. Nichol, Ph.D.

Jae Jin An, Ph.D. Michael B. Nichol, Ph.D. IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIAS Jae Jin An, Ph.D. Michael B. Nichol, Ph.D.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.

More information

Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study

Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study Clinical Outcomes of Women with Peripartum Cardiomyopathy With and Without Preeclampsia: a Population-based Study Isabelle Malhamé, MSc Candidate in Epidemiology, McGill University Obstetric Medicine Fellow,

More information

ANALYSIS OF KENTUCKY MEDICAID MANAGED CARE VERSUS FEE-FOR- SERVICE SYSTEMS: MEDICATION ADHERENCE IN PATIENTS WITH PREVALENT CHRONIC DISEASES

ANALYSIS OF KENTUCKY MEDICAID MANAGED CARE VERSUS FEE-FOR- SERVICE SYSTEMS: MEDICATION ADHERENCE IN PATIENTS WITH PREVALENT CHRONIC DISEASES University of Kentucky UKnowledge Theses and Dissertations--Pharmacy College of Pharmacy 2016 ANALYSIS OF KENTUCKY MEDICAID MANAGED CARE VERSUS FEE-FOR- SERVICE SYSTEMS: MEDICATION ADHERENCE IN PATIENTS

More information

Report to the Social Services Appropriations Subcommittee

Report to the Social Services Appropriations Subcommittee Report to the Social Services Appropriations Subcommittee Medicaid Coverage and Reimbursement for Outpatient Physical Therapy and Outpatient Occupational Therapy Prepared by the Division of Medicaid and

More information

Payers continue to search for effective ways to control

Payers continue to search for effective ways to control At a Glance Practical Implications p 218 Author Information p 221 Full text and PDF www.ajpblive.com Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes Benefit

More information

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology

More information

HUSKY Health Benefits and Prior Authorization Requirements Grid* Behavioral Health Partnership Effective: January 1, 2012

HUSKY Health Benefits and Prior Authorization Requirements Grid* Behavioral Health Partnership Effective: January 1, 2012 Behavioral Health Health and Behavior Assessments (CPT 96150-96155) When Performed by Psychologists Mental Health Inpatient 100% covered under medical benefit for members with diagnoses outside the range

More information

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Renoux C, Vahey S, Dell Aniello S, Boivin J-F. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol. Published

More information

Reporting Periods in 2010

Reporting Periods in 2010 Reporting Periods in 2010 1. Full Year (January 1, 2010 December 31, 2010) eligible professionals (EP) whose PQRI quality measure information is successfully submitted (via claims, measures group, or registry)

More information

Status of the CKD and ESRD treatment: Growth, Care, Disparities

Status of the CKD and ESRD treatment: Growth, Care, Disparities Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Saloner B, Levin J, Chang H-Y, Jones C, Alexander GC. Changes in buprenorphinenaloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion.

More information

Disease Management. Measures At A Glance

Disease Management. Measures At A Glance s At A Glance Updated: 11/01/2018 URAC 2018 Page 1 of 7 Cross-Cutting Mandatory s (3) Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to URAC on

More information

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

SAMPLE. Laboratory Services. An essential coding, billing, and reimbursement resource for laboratory and pathology services ICD-10

SAMPLE. Laboratory Services. An essential coding, billing, and reimbursement resource for laboratory and pathology services ICD-10 Coding and Payment Guide www.optumcoding.com Laboratory Services An essential coding, billing, and reimbursement resource for laboratory and pathology services 2017 ICD-10 A full suite of resources including

More information

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5 National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION CPT Codes: 93451, 93452, 93453, 93454, 93455, 93456, 93457, 93458, 93459, 93460, 93461 LCD ID Number:

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Hayes J, Jackson JL, McNutt GM, Hertz BJ, Ryan JJ, Pawlikowski SA. Association between physician time-unlimited vs time-limited internal medicine board certification and ambulatory

More information

Sample page. For the Physical Therapist An essential coding, billing and reimbursement resource for the physical therapist CODING & PAYMENT GUIDE

Sample page. For the Physical Therapist An essential coding, billing and reimbursement resource for the physical therapist CODING & PAYMENT GUIDE CODING & PAYMENT GUIDE 2019 For the Physical Therapist An essential coding, billing and reimbursement resource for the physical therapist Power up your coding optum360coding.com Contents Getting Started

More information

Charge Posting. General Principles. Insurance Payments for Services

Charge Posting. General Principles. Insurance Payments for Services Charge Posting General Principles Insurance Payments for Services ICD-9 Codes are the diagnostic codes used by insurance companies, including Medicare, for determining whether a service is going to paid

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kappos L, Li DKB, Stüve O, et al. Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis: dose-blinded, randomized extension of the

More information

The Impact of Financial Wellness Incentives on Hospitalizations and Medical Care Use

The Impact of Financial Wellness Incentives on Hospitalizations and Medical Care Use The Impact of Financial Wellness Incentives on Hospitalizations and Medical Care Use Gautam Gowrisankaran, Ph.D. Karen Norberg, M.D. Steven Kymes, Ph.D. Michael Chernew, Ph.D. Dustin Stwalley, M.A. Leah

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Steinhubl SR, Waalen J, Edwards AM, et al. Effect of a home-based wearable continuous electrocardiographic monitoring patch on detection of undiagnosed atrial fibrillation

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices

More information

Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy

Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy Policy Number Physical Medicine & Rehabilitation: Maximum Combined Frequency per Day Policy 2017R0101E Annual Approval Date 7/13/2016 Approved By Payment Policy Oversight Committee IMPORTANT NOTE ABOUT

More information

Counseling to Prevent Tobacco Use

Counseling to Prevent Tobacco Use News Flash Vaccination is the Best Protection Against the Flu. This year, the Centers for Disease Control and Prevention (CDC) is encouraging everyone 6 months of age and older to get vaccinated against

More information

medicaid and the The Role of Medicaid for People with Diabetes

medicaid and the The Role of Medicaid for People with Diabetes on medicaid and the uninsured The Role of for People with Diabetes November 2012 Introduction Diabetes is one of the most prevalent chronic conditions and a leading cause of death in the United States.

More information

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction Measure #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET PQRS in TRAKnet 2015 GUIDE TO SUBMITTING AND REPORTING PQRS IN 2015 THROUGH TRAKNET What is PQRS? PQRS is a quality reporting program that uses negative payment adjustments to promote reporting of quality

More information

Geographic variations in incremental costs of heart disease among medicare beneficiaries, by type of service, 2012

Geographic variations in incremental costs of heart disease among medicare beneficiaries, by type of service, 2012 Geographic variations in incremental costs of heart disease among medicare beneficiaries, by type of service, 2012 Rita Wakim, Centers for Disease Control and Prevention Matthew Ritchey, Centers for Disease

More information

Understanding Hierarchical Condition Categories (HCC)

Understanding Hierarchical Condition Categories (HCC) Understanding Hierarchical Condition Categories (HCC) How hierarchical condition category coding will impact your practice and how you can use these codes to increase quality, improve the patient experience,

More information

KEY BEHAVIORAL MEASURES

KEY BEHAVIORAL MEASURES 2019 HEDIS AT-A-GLANCE: KEY BEHAVIORAL MEASURES (17 Years and Younger) At WellCare, we value everything you do to deliver quality care for our members your patients to make sure they have a positive healthcare

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

Risk adjustment in health care markets: concepts and applications. Randall P. Ellis. Boston University and DxCG, Inc.

Risk adjustment in health care markets: concepts and applications. Randall P. Ellis. Boston University and DxCG, Inc. Risk adjustment in health care markets: concepts and applications Randall P. Ellis. Boston University and DxCG, Inc. Slides prepared for the Risk Adjustment Network (RAN) meeting in Dublin Ireland, March

More information

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO ACO-1 ACO-2 Getting Timely Care, Appointments, and Information How Well Your Providers

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

Six Major Section Of The Cpt Manual

Six Major Section Of The Cpt Manual Six Major Section Of The Cpt Manual What section of the CPT manual would you find the code for a superficial abscess of the skin of the penis? What are the major sections of the CPT manual? 1. A discussion

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Diagnosis Coding is About to be Much More Important. Matthew Menendez

Diagnosis Coding is About to be Much More Important. Matthew Menendez Diagnosis Coding is About to be Much More Important Matthew Menendez Agenda What is CMS doing with MACRA? What is an HCC code and why should I care? Brief MIPS overview How does risk adjustment impact

More information

Pharmacogenomic Testing for Warfarin Response (NCD 90.1)

Pharmacogenomic Testing for Warfarin Response (NCD 90.1) Policy Number 90.1 Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 01/08/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare

More information

Lumify. Lumify reimbursement guide {D DOCX / 1

Lumify. Lumify reimbursement guide {D DOCX / 1 Lumify Lumify reimbursement guide {D0672917.DOCX / 1 {D0672917.DOCX / 1 } Contents Overview 4 How claims are paid 4 Documentation requirements 5 Billing codes for ultrasound: Non-hospital setting 6 Billing

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Regional and Racial Variation in Primary Care and the Quality of Care Among Medicare Beneficiaries

Regional and Racial Variation in Primary Care and the Quality of Care Among Medicare Beneficiaries MethodsfortheDartmouthAtlasofHealthCareReport: RegionalandRacialVariationinPrimaryCareandthe QualityofCareAmongMedicareBeneficiaries September2010 DavidGoodman,MDMS ShannonBrownlee,MS Chiang HuaChang,PhD

More information

Position Statement on ALDOSTERONE ANTAGONIST THERAPY IN CHRONIC HEART FAILURE

Position Statement on ALDOSTERONE ANTAGONIST THERAPY IN CHRONIC HEART FAILURE Position Statement on ALDOSTERONE ANTAGONIST THERAPY IN CHRONIC HEART FAILURE Over 8,000 patients have been studied in two well-designed placebo-controlled outcome-driven clinical trials to evaluate the

More information

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling

More information

Introduction to HEDIS 2016 Presented by the Quality Improvement Department at Gold Coast Health Plan

Introduction to HEDIS 2016 Presented by the Quality Improvement Department at Gold Coast Health Plan Introduction to HEDIS 2016 Presented by the Quality Improvement Department at Gold Coast Health Plan Ventura County s Medi-Cal Managed Care Plan Serving Ventura County since July 1, 2011 1 Contents I.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Jørgensen ME, Hlatky MA, Køber L, et al. β-blocker associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Intern Med. Published online

More information

1-844-FAX-A360 ( )

1-844-FAX-A360 ( ) 1-844-ASK-A360 (1-844-275-2360) 1-844-FAX-A360 (1-844-329-2360) www.myaccess360.com For more information, call AstraZeneca Access 360 at 1-844-ASK-A360, Monday through Friday, 8 am to 8 pm ET. IMFINZI

More information

Chapter 4 Section 24.2

Chapter 4 Section 24.2 Surgery Chapter 4 Section 24.2 Issue Date: December 11, 1986 Authority: 32 CFR 199.4(e)(5) 1.0 CPT 1 PROCEDURE CODES 33940-33945, 33975-33980 2.0 POLICY 2.1 Benefits are allowed for heart transplantation.

More information

ICD-10CM, HCC and Risk Adjustment Factor

ICD-10CM, HCC and Risk Adjustment Factor ICD-10CM, HCC and Risk Adjustment Factor Not everyone is aware of what CMs calls the risk adjustment model. It was developed under the Patient Protection and Affordable Care Act (also known as the PACA)

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lau WCY, Chan EW, Cheung CL, et al. Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA.

More information

A Provider s Guide to Sustainability and Reimbursement of HIV Testing in Florida Health Care Facilities

A Provider s Guide to Sustainability and Reimbursement of HIV Testing in Florida Health Care Facilities A Provider s Guide to Sustainability and Reimbursement of HIV Testing in Florida Health Care Facilities April 2011 www.fcaetc.org www.floridaaids.org USF Center for HIV Education and Research Publication

More information

2018 Cerebrovascular Reimbursement Coding Fact Sheet

2018 Cerebrovascular Reimbursement Coding Fact Sheet The information contained in this document is provided for informational purposes only and represents no statement, promise, or guarantee by Cordis Corporation concerning levels of reimbursement, payment,

More information

Combining Risk Adjustment and HEDIS to Improve Quality of Care. Colleen Gianatasio, CPC, CPC-P, CPMA, CPC-I, CRC

Combining Risk Adjustment and HEDIS to Improve Quality of Care. Colleen Gianatasio, CPC, CPC-P, CPMA, CPC-I, CRC Combining Risk Adjustment and HEDIS to Improve Quality of Care Colleen Gianatasio, CPC, CPC-P, CPMA, CPC-I, CRC Agenda Improving primary care in today s health care environment Risk adjustment basics (using

More information

Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Spending

Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Spending 1 Funding from the National Institute on Aging (T32-AG000186 to the National Bureau of Economic Research and P01-AG019783 to Dartmouth) and LEAP at Harvard University. Survey data collected under P01-AG019783

More information

ProviderNews2015. a growing issue. Body mass index and obesity: Tips and tools for tackling

ProviderNews2015. a growing issue. Body mass index and obesity: Tips and tools for tackling GeorgiA ProviderNews2015 Quarter 2 Body mass index and obesity: Tips and tools for tackling a growing issue For adults, overweight and obesity ranges are determined by using weight and height to calculate

More information

Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery (NCD 20.2)

Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery (NCD 20.2) Policy Number 20.2 Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 05/28/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare

More information

Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice

Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice CONTINUING EDUCATION Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice GOAL To provide participants with current information about current blood pressure goals and effective

More information